BRIEF-Tibet Aim Pharm sees H1 FY 2017 net profit down 18.6 pct to up 30.2 pct - Reuters

BRIEF-Tibet Aim Pharm sees H1 FY 2017 net profit down 18.6 pct to up 30.2 pct Reuters Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news ... and more »

http://ift.tt/2pssjfK